Stonebrook Private’s Amgen AMGN Stock Holding History

Stonebrook Private’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$275K	Buy	781 +88	+13%	+$31.4K	0.06%	174
2025 Q4	$227K	Buy	+693	New	+$220K	0.05%	183

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Stonebrook Private's AMGN Position: Q1 2026 in Review

Stonebrook Private increased its Amgen (AMGN) stake by 13% in Q1 2026, buying an estimated $31.4K and bringing the position to 781 shares worth $275K. The position accounts for 0.06% of the portfolio, ranked #174.

Stonebrook Private first reported a position in AMGN in Q4 2025 and has held it in 2 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Stonebrook Private held 781 shares of Amgen worth $275K as of Q1 2026.
Stonebrook Private bought 88 Amgen shares in Q1 2026, an estimated $31.4K.
Amgen made up 0.06% of Stonebrook Private's portfolio in Q1 2026, its #174 holding.
Stonebrook Private first reported a position in Amgen in Q4 2025 and has held it in 2 quarters since.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Stonebrook Private's 13F filing for Q1 2026, filed 11 May 2026.